http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112521507-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2800-107 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-85 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2863 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-85 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-13 |
filingDate | 2020-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2021-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2021-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-112521507-B |
titleOfInvention | Anti-human c-Met human-mouse chimeric monoclonal antibody and application thereof |
abstract | The invention provides an anti-human c-Met human mouse chimeric monoclonal antibody and application thereof, belonging to the technical field of enzyme-linked immunity, wherein the nucleotide sequences of a 1D20 heavy chain variable region and a 1D20 light chain variable region of the c-Met targeted human mouse chimeric monoclonal antibody are sequentially shown as SEQ ID No.1 and SEQ ID No. 2. The c-Met-targeted human mouse chimeric monoclonal antibody provided by the invention can be specifically combined with the c-Met with high affinity, is chimeric with a human antibody constant region, can generate a slight immunological rejection reaction compared with a mouse monoclonal antibody when applied in a human body, and improves the application value of a product. |
priorityDate | 2020-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 343.